ANDREW GUGGENHIME - 24 May 2021 Form 4 Insider Report for Metacrine, Inc. (MTCR)

Role
Director
Signature
/s/ Catherine C. Lee, Attorney-in-fact for Andrew Guggenhime
Issuer symbol
MTCR
Transactions as of
24 May 2021
Transactions value $
$0
Form type
4
Filing time
25 May 2021, 18:55:30 UTC
Next filing
22 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MTCR Stock Option (right to buy) Award $0 +16.5K $0.00 16.5K 24 May 2021 Common Stock 16.5K $4.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day immediately prior to the date of the Issuer's 2022 annual meeting of stockholders.